• Our Mission
  • Clinical Trials Scoreboard
  • What is Congress Doing?
  • Contact Us

Myasthenia Gravis

Latest News in Myasthenia Gravis


April 30, 2025

FDA Approves New Monoclonal Antibody for Myasthenia Gravis – Medscape


April 30, 2025

J&J joins Argenx, UCB in the myasthenia gravis arena with FDA approval for FcRn blocker Imaavy – Fierce Pharma


April 30, 2025

FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis – Applied Clinical Trials


April 30, 2025

FDA Approves Nipocalimab for Generalized Myasthenia Gravis – AJMC


April 30, 2025

FDA Approves Johnson & Johnson’s IMAAVY™ (nipocalimab-aahu) a New Treatment for Myasthenia Gravis (MG), Offering Hope for Families – Muscular Dystrophy Association

  • «
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 20
  • »

110 Active Myasthenia Gravis Clinical Trials

As of June 21, 2025

Source: clinicaltrials.gov

Click here to see other conditions

LOCATE

CLINICAL TRIALS

BROWSE

FDA-approved DRUGS

WHAT IS

CONGRESS DOING?

© Copyright 2020-2025 Seeking Cure, Inc. All Rights Reserved. Third Party materials included herein protected under copyright law.

Seeking Cure is a registered trademark of Seeking Cure, Inc.

Use of this website and any information contained herein is governed by Seeking Cure’s Terms of Service and Privacy Policy. This website is provided for general information purposes only. This website does not provide medical advice. Always consult an appropriately licensed medical provider for diagnosis and treatment. Seeking Cure does not warrant the accuracy, completeness, or timeliness of the information. Content and other features are subject to change or termination without notice at the discretion of Seeking Cure.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • Follow
  • Follow

We use cookies to improve your experience on our website. By continuing to use this website, you agree to our Terms of Service and Privacy Policy. To learn more about how we use cookies, please see our Privacy Policy.

You are now leaving the Seeking Cure website. Seeking Cure offers links to other third party websites that may be of interest to our website visitors. Seeking Cure is not responsible for the products, services, and content on the third party website. We make no representation or warranty regarding the accuracy of the information contained in the linked sites.

Also, please be aware that the security and privacy policies on these sites may be different than Seeking Cure’s policies. When you use a third party site, you will be subject to its terms and licenses.

By clicking on the CONTINUE button below, you acknowledge the above statement and will be taken to the linked site.

Continue